Extremely High Systemic Immune Inflammation Levels Increase the Risk of All-Cause and Cardiovascular Mortality in Postmenopausal Women

Fei Wu,1 Jiantong Yang,1 Yinchuan Liu,1 Yipei Zhang2 1Department of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, 330006, People’s Republic of China; 2Department of Gynecology, Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, Jiangxi, 330008, People’s Republic of ChinaCorrespondence: Yipei Zhang, Department of Gynecology, Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, Jiangxi, 330008, People’s Republic of China, Email [email protected]: The systemic immune inflammation (SII) index provides a comprehensive assessment of inflammatory and immune status in patients with different diseases. However, it remains unclear whether the SII can be considered a valuable prognostic risk factor of all-cause mortality for postmenopausal women.Methods: We analyzed data from 1882 postmenopausal women enrolled in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. The Systemic Immune-Inflammation Index (SII) was calculated using peripheral blood cell counts and categorized into quartiles. Multivariable Cox proportional hazards models and restricted cubic spline analyses were employed to assess the association between SII and mortality outcomes.Results: Over a median follow-up period of 8 years, 13.5% individuals died, with 4% deaths attributed to CVD. Patients with extremely high SII levels experienced significantly higher all-cause and CVD mortality. Compared to the low SII group (Q1), the hazard ratio (HR) and 95% confidence interval (CI) for all-cause mortality risk were 0.96 (0.87, 1.07), 0.97 (0.88, 1.08), and 1.28 (1.16, 1.41) for Q2, Q3, and Q4, respectively. Similarly, the HR (95% CI) for CVD mortality in Q2, Q3, and Q4 were 1.02 (0.83, 1.24), 1.11 (0.92, 1.34), and 1.32 (1.10, 1.58), respectively. Including SII in addition to traditional risk factors resulted in a slight enhancement in mortality prediction capability.Conclusion: Among postmenopausal women, extremely high SII levels were identified as an independent risk factor for all-cause and CVD mortality.Keywords: systemic immune inflammation, mortality, postmenopausal women, women health, cardiovascular disease

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-05-01
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extremely High Systemic Immune Inflammation Levels Increase the Risk of All-Cause and Cardiovascular Mortality in Postmenopausal Women

SHILAP Revista de lepidopterología
Inflammatory Biomarkers in Disease Prognosis
article

Extremely High Systemic Immune Inflammation Levels Increase the Risk of All-Cause and Cardiovascular Mortality in Postmenopausal Women

article en

Abstract

Fei Wu,1 Jiantong Yang,1 Yinchuan Liu,1 Yipei Zhang2 1Department of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, 330006, People’s Republic of China; 2Department of Gynecology, Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, Jiangxi, 330008, People’s Republic of ChinaCorrespondence: Yipei Zhang, Department of Gynecology, Nanchang Hongdu Hospital of Traditional Chinese Medicine, Nanchang, Jiangxi, 330008, People’s Republic of China, Email [email protected]: The systemic immune inflammation (SII) index provides a comprehensive assessment of inflammatory and immune status in patients with different diseases. However, it remains unclear whether the SII can be considered a valuable prognostic risk factor of all-cause mortality for postmenopausal women.Methods: We analyzed data from 1882 postmenopausal women enrolled in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. The Systemic Immune-Inflammation Index (SII) was calculated using peripheral blood cell counts and categorized into quartiles. Multivariable Cox proportional hazards models and restricted cubic spline analyses were employed to assess the association between SII and mortality outcomes.Results: Over a median follow-up period of 8 years, 13.5% individuals died, with 4% deaths attributed to CVD. Patients with extremely high SII levels experienced significantly higher all-cause and CVD mortality. Compared to the low SII group (Q1), the hazard ratio (HR) and 95% confidence interval (CI) for all-cause mortality risk were 0.96 (0.87, 1.07), 0.97 (0.88, 1.08), and 1.28 (1.16, 1.41) for Q2, Q3, and Q4, respectively. Similarly, the HR (95% CI) for CVD mortality in Q2, Q3, and Q4 were 1.02 (0.83, 1.24), 1.11 (0.92, 1.34), and 1.32 (1.10, 1.58), respectively. Including SII in addition to traditional risk factors resulted in a slight enhancement in mortality prediction capability.Conclusion: Among postmenopausal women, extremely high SII levels were identified as an independent risk factor for all-cause and CVD mortality.Keywords: systemic immune inflammation, mortality, postmenopausal women, women health, cardiovascular disease

SHILAP Revista de lepidopterología
Jiangxi Maternal and Child Health Hospital (CN)
Good health and well-being
Openalex Percentile: Top 38%
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.